Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview

MG Matera, B Rinaldi, C Belardo… - Expert Review of Clinical …, 2022 - Taylor & Francis
Introduction Long-acting muscarinic receptor antagonist (LAMA)/β2-agonist (LABA)
combinations represent a significant improvement in the treatment of chronic obstructive …
被引用次数：2 相关文章

Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview.

MG Matera, B Rinaldi, C Belardo… - Expert Review of Clinical …, 2022 - europepmc.org
Long-acting muscarinic receptor antagonist (LAMA)/β 2-agonist (LABA) combinations
represent a significant improvement in the treatment of chronic obstructive pulmonary …

Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview

MG Matera, B Rinaldi, C Belardo… - Expert review of …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Long-acting muscarinic receptor antagonist (LAMA)/β 2-agonist (LABA)
combinations represent a significant improvement in the treatment of chronic obstructive …

Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview

MG Matera, B Rinaldi, C Belardo… - EXPERT REVIEW OF …, 2022 - iris.unicampania.it
Introduction Long-acting muscarinic receptor antagonist (LAMA)/beta (2)-agonist (LABA)
combinations represent a significant improvement in the treatment of chronic obstructive …